Stocks on the Move: Hovnanian Enterprises, Inc. (HOV), Tyson Foods, Inc. (TSN), SM Energy Company (SM)

Hovnanian Enterprises, Inc. (HOV) continued its upward trend with the stock climbing 5.99% or $0.13 to close the day at $2.3 on active trading volume of 4.35M shares, compared to its three month average trading volume of 1.2M. The Red Bank New Jersey 07701 based company has been outperforming the residential construction group over the past 52 weeks, with the stock gaining 28.49%, compared to the industry which has dropped -10.5% over the same period. With RSI of 89.32, the stock should still continue to rise and get closer to its one year target estimate of $1.88, making it a hold for now.

Hovnanian Enterprises, Inc. designs, constructs, markets, and sells residential homes in the United States. It constructs single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes. The company markets its build homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active lifestyle buyers, and empty nesters in 219 communities in 34 markets. It also provides financial services comprising originating mortgages from homebuyers and selling such mortgages in the secondary market, as well as offers title insurance services. The company was founded in 1959 and is headquartered in Red Bank, New Jersey.

Tyson Foods, Inc. (TSN) climbed 0.39% during last trading as the stock added $0.22 to finish the day at $57.27 with about 4.35M shares changing hands, compared to its three month average trading volume of 4.03M. The $20.33B market cap company, which fluctuated between $56.84 and $57.96 during the day, currently situated 19.27% above its 52 week low of $48.52 and -25.38% away from its one year high of $77.05. The RSI of 32.39 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

SM Energy Company (SM) saw its value decrease by -2.54% as the stock dropped $-0.99 to finish the day at a closing price of $37.91. The stock was higher in trading and has fluctuated between $6.99-$43.09 per share for the past year. The shares, which traded within a range of $37.87 to $40.04 during the day, are down by -2.77% in the past three months and up by 9.42% over the past six months. It is currently trading 10% above its 20 day moving average and 4.66% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $47.73 a share over the next twelve months. The current relative strength index (RSI) reading is 55.32. The technical indicator lead us to believe there will be no major movement any time soon, hold.

SM Energy Company, an independent energy company, engages in the acquisition, exploration, development, and production of crude oil and condensate, natural gas, and natural gas liquids in onshore North America. It primarily has operations in the South Texas and Gulf Coast region, which focuses primarily on Eagle Ford shale program; Rocky Mountain region comprising the Bakken and Three Forks formations in the North Dakota; and Permian region covering western Texas and southeastern New Mexico. As of December 31, 2015, the company had 471.3 million barrels of oil equivalent of estimated proved reserves; and working interests in 872 net productive oil wells and 653 net productive gas wells. The company was formerly known as St. Mary Land & Exploration Company and changed its name to SM Energy Company in May 2010. SM Energy Company was founded in 1908 and is headquartered in Denver, Colorado.

 

Stocks Highlights: Medical Properties Trust, Inc. (MPW), BioPharmX Corporation (BPMX), Tyson Foods, Inc. (TSN)

Medical Properties Trust, Inc. (MPW) had a light trading with around 3.65M shares changing hands compared to its three month average trading volume of 5.18M. The stock traded between $11.78 and $12.06 before closing at the price of $11.87 with 1.02% change on the day. The Birmingham Alabama 35242 based company is currently trading 29.77% above its 52 week low of $9.61 and -24.22% below its 52 week high of $15.92. Both the RSI indicator and target price of 35.39 and $14.44 respectively, lead us to believe that it should be put on hold over the coming weeks.

Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The company also provides mortgage loans to healthcare operators, as well as working capital and other term loans to its tenants/borrowers. As of February 24, 2011, its portfolio consisted of 58 properties, including 22 general acute care hospitals, 17 long-term acute care hospitals, 9 inpatient rehabilitation hospitals, 2 medical office buildings, and 6 wellness centers, as well as 2 non-owned general acute care facilities. The company has elected to be taxed as a REIT under the Tax Code. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its REIT taxable income to its shareholders. The company was founded in 2003 and is based in Birmingham, Alabama.

BioPharmX Corporation (BPMX) managed to rebound with the stock climbing 32.26% or $0.1 to close the day at $0.41 on active trading volume of 3.63M shares, compared to its three month average trading volume of 276.25K. The Menlo Park California 94025 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -66.67%, compared to the industry which has dropped -4.15% over the same period. With RSI of 65.28, the stock should still continue to rise and get closer to its one year target estimate of $3, making it a hold for now.

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women’s health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (FBC). The company’s clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician’s practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.

Tyson Foods, Inc. (TSN) shares were up in last trading by 1.57% to $57.05. It experienced lighter than average volume on day. The stock decreased in value by almost -3.99% over the past week and fell -18.55% in the past month. It is currently trading -16.96% below its 50 day moving average and -16.11% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -25.67% decrease in value from its one year high of $77.05. The RSI indicator value of 31.87, lead us to believe that it is a hold for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

 

3 Stocks to Watch For: Sarepta Therapeutics, Inc. (SRPT), FireEye, Inc. (FEYE), Tyson Foods, Inc. (TSN)

Sarepta Therapeutics, Inc. (SRPT) saw its value decrease by -6.01% as the stock dropped $-2.06 to finish the day at a closing price of $32.2. The stock was higher in trading and has fluctuated between $8-$63.73 per share for the past year. The shares are up by 21.23% in the past three months and up by 106.81% over the past six months. It is currently trading -15.53% below its 20 day moving average and -31.76% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $71.63 a share over the next twelve months. The current relative strength index (RSI) reading is 25.63.The technical indicator lead us to believe the stock will reverse recent losses any time soon.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. The company’s lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which is in Phase III clinical development for the treatment of individuals with Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease caused by the absence of dystrophin. It is also developing exon-skipping drugs for the treatment of DMD; and therapeutic candidates for the treatment of infectious diseases, such as influenza, Marburg, and Ebola. The company has a strategic alliance with Charley’s Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies; a license agreement with the University of Western Australia for the use of antisense sequences in the treatment of DMD; and a research collaboration agreement with Catabasis Pharmaceuticals, Inc to explore a combination drug treatment approach for DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

FireEye, Inc. (FEYE) shares were down in last trading by -3.58% to $12.38. It experienced higher than average volume on day. The stock decreased in value by almost -7.27% over the past week and grew 3.95% in the past month. It is currently trading -6.74% below its 50 day moving average and -19.68% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -46.02% decrease in value from its one year high of $23.62. The RSI indicator value of 38.73, lead us to believe that it is a hold for now.

FireEye, Inc. provides cybersecurity solutions for detecting, preventing, analyzing, and resolving cyber-attacks. The company offers vector-specific appliance solutions that provide threat protection from network to endpoint for inbound and outbound network traffic that may contain sensitive information. It also offers Central Management System that provides cross-enterprise threat data correlation to identify and block attacks across multiple attack vectors; and Threat Analytics Platform to identify and respond to cyber threats by correlating enterprise-generated security event data from any security product with real-time threat intelligence, as well as Malware Analysis System to manually execute and inspect advanced malware, zero-day, and other advanced cyber-attacks embedded in files, email attachments, and Web objects. In addition, the company offers Network Forensics Platform that helps in detecting threats and view specific packets and sessions before, during, and after the attack to confirm what may have triggered a malware download or callback; Investigation Analysis System, a centralized analytical interface to the Network Forensics Platform; and Mandiant Intelligent Response that enables remote investigation of endpoints and allows security teams to collect targeted forensic data to identify attacker behavior, tools, and techniques. Further, it provides cloud-based subscription services; Security-as-a-Service; and incident response, compromise assessments, and related consulting, as well as training and professional, and customer support and maintenance services. FireEye, Inc. provides its products and services through distributors, resellers, and strategic partners in the United States, the Asia Pacific, Japan, Europe, the Middle East, Africa, and others. The company was formerly known as NetForts, Inc. and changed its name to FireEye, Inc. in September 2005. FireEye, Inc. was founded in 2004 and is headquartered in Milpitas, California.

Tyson Foods, Inc. (TSN) traded within a range of $55.94 to $57.18 after opening the day at $56.81. The company has seen its stock increase in value by 6.43% so far this year. The stock was down close to -1.13% on active volume in last trading session and closed at $56.17 per share. After the recent fall, the stock is currently holding -26.82% below its 52 week high of $77.05 and 16.98% above its 12-month low of $48.52. The shares are down by over -25.29% in the last three months, and the RSI indicator value of 28.75 is bullish. They are not pointing to a rebound in the stock. We should get in as it looks to have found a bottom.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

 

Worth Watching Stocks: Amicus Therapeutics, Inc. (FOLD), Tyson Foods, Inc. (TSN), Texas Instruments Incorporated (TXN)

Amicus Therapeutics, Inc. (FOLD) saw its value decrease by -8.14% as the stock dropped $-0.53 to finish the day at a closing price of $5.98. The stock was higher in trading and has fluctuated between $4.98-$11.58 per share for the past year. The shares are down by -10.61% in the past three months and down by -22.44% over the past six months. It is currently trading -26.77% below its 20 day moving average and -22.61% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $12.38 a share over the next twelve months. The current relative strength index (RSI) reading is 31.05.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical study for the treatment of the genetic connective tissue disorder epidermolysis bullosa; ATB200 that is in Phase II studies to treat pompe disease; AT2221, which is in Phase II studies for the treatment of pompe disease; and AT3375 to treat Parkinson’s disease. The company has strategic alliance with GlaxoSmithKline plc to develop and commercialize migalastat as a monotherapy and in combination with ERT for Fabry disease. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Tyson Foods, Inc. (TSN) shares were down in last trading by -3.65% to $56.81. It experienced higher than average volume on day. The stock decreased in value by almost -3.27% over the past week and fell -19.51% in the past month. It is currently trading -18.19% below its 50 day moving average and -16.53% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -25.98% decrease in value from its one year high of $77.05. The RSI indicator value of 29.37, lead us to believe that it may correct downwards in the near term.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

Texas Instruments Incorporated (TXN) opening the day at $74.67. The company has seen its stock increase in value by 38.51% so far this year. The stock was down close to -0.63% on active volume in last trading session and closed at $73.93 per share. After the recent fall, the stock is currently holding -1.75% below its 52 week high of $74.89 and 62.46% above its 12-month low of $46.73. The shares are up by over 7.09% in the last three months, and the RSI indicator value of 66.26 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power management products that include catalog and application-specific standard products to enhance the efficiency of powered devices using battery management solutions, portable power conversion devices, power supply controls, and point-of-load products. This segment also provides high performance analog products, such as high-speed data converters, amplifiers, sensors, high reliability products, interface products, and precision products; and silicon valley analog products, including power management, data converter, interface, and operational amplifier catalog analog products that are used in manufacturing various electronic systems. The Embedded Processing segment offers microcontroller products, which are systems with a processor core, memory, and peripherals to control a set of specific tasks for electronic equipment; processor products comprising digital signal and applications processors; and connectivity products consisting of electronic devices to connect and transfer data. The company also provides DLP products primarily used in projectors to create high-definition images; application-specific integrated circuits; calculators; and baseband products, as well as OMAP applications processors and connectivity products. It markets and sells its products through a direct sales force and distributors. Texas Instruments Incorporated was founded in 1930 and is headquartered in Dallas, Texas.

 

Trader Alert: Citizens Financial Group, Inc. (CFG), Tyson Foods, Inc. (TSN), The Bank of New York Mellon Corporation (BK)

Citizens Financial Group, Inc. (CFG) grew with the stock adding 1.92% or $-0.68 to close at $31.78 on light trading volume of 5.71M compared its three months average trading volume of 5.97M. The Providence Rhode Island 02903 based company has been trending up for the last 52 weeks, with the shares price now 24.09% up for the period and up by 26.18% so far this year. With price target of $29.95 and a 82.3% rebound from 52-week low, Citizens Financial Group, Inc. has plenty of upside potential, making it a hold with a view buy.

Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United States. It operates through two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment focuses on retail customers and small businesses with traditional banking products and services, including checking, savings, home loans, student loans, credit cards, business loans, and financial management services. This segment also provides indirect auto finance for new and used vehicles through auto dealerships. The Commercial Banking segment provides various financial products and solutions, including loans, leases, trade financing, deposits, cash management, foreign exchange, interest rate risk management, corporate finance, and capital markets advisory capabilities. It focuses on small and middle-market companies, and serves government banking, not-for-profit, healthcare, technology, asset finance, franchise finance, asset-based lending, commercial real estate, private equity, and sponsor finance industries. As of December 31, 2015, the company operated through 1,200 branches in 11 states across the New England, Mid-Atlantic, and Midwest regions, as well as online, telephone, and mobile banking platforms. It also maintains approximately 100 retail and commercial non-branch offices located in its banking footprint and in other states, and the District of Columbia. The company was formerly known as RBS Citizens Financial Group, Inc. and changed its name to Citizens Financial Group, Inc. in April 2014. Citizens Financial Group, Inc. was founded in 1828 and is headquartered in Providence, Rhode Island.

Tyson Foods, Inc. (TSN) gained $0.62 to close the day at a new closing price of $58.96, a 1.06% increase in value from its previous closing price that moved the stock 22.31% above its 52 week low of $48.52. A total of 5.67M shares exchanged hands during the day compared with its three month average trading volume of 3.79M. The stock, which fluctuated between $58.18 and $59.75 during the day, currently situated -23.48% below its 52 week high. The stock is down by -15.46% in the past one month and down by -21.83% over the past three months. With a one year target estimate of $70.9 and RSI of 32.07, the stock still has upside potential, making it a hold for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

The Bank of New York Mellon Corporation (BK) shares were up in last trading by 0.04% to $47.05. It experienced lighter than average volume on day. The stock decreased in value by almost -0.78% over the past week and grew 8.16% in the past month. It is currently trading 10.25% above its 50 day moving average and 18.25% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.9% decrease in value from its one year high of $47.96. The RSI indicator value of 67.26, lead us to believe that it is a hold for now.

The Bank of New York Mellon Corporation, an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It operates through two segments, Investment Management and Investment Services. The company offers investment management; trust and custody; foreign exchange; fund administration; global collateral services; securities lending; depositary receipts; corporate trust; global payment/cash management; banking services; and clearing services. It also provides mutual funds, separate accounts, wealth management and private banking services; and broker-dealer services, registered investment advisory services, prime brokerage services, and working capital solutions. In addition, the company is involved in credit-related activities, business exits, leasing operations, and corporate treasury activities; and the provision of global markets and institutional banking services. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

 

Stocks To Track: Pepsico, Inc. (PEP), Tyson Foods, Inc. (TSN), The Southern Company (SO)

Pepsico, Inc. (PEP) climbed 0.61% during last trading as the stock added $0.62 to finish the day at $102.79 with about 5.53M shares changing hands, compared to its three month average trading volume of 4.36M. The $147.42B market cap company, which fluctuated between $101.9 and $103.25 during the day, currently situated 12.64% above its 52 week low of $93.25 and -6.69% away from its one year high of $110.94. The RSI of 42.84 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

PepsiCo, Inc. operates as a food and beverage company worldwide. Its Frito-Lay North America segment offers Lay’s and Ruffles potato chips; Doritos, Tostitos, and Santitas tortilla chips; and Cheetos cheese-flavored snacks, branded dips, and Fritos corn chips. The company’s Quaker Foods North America segment provides Quaker oatmeal, grits, rice cakes, natural granola, and oat squares; and Aunt Jemima mixes and syrups, Quaker Chewy granola bars, Cap’n Crunch cereal, Life cereal, and Rice-A-Roni side dishes. Its North America Beverages segment offers beverage concentrates, fountain syrups, and finished goods under the Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Tropicana Pure Premium, Sierra Mist, and Mug brands; and ready-to-drink tea and coffee, and juices. The company’s Latin America segment provides snack foods under the Doritos, Cheetos, Marias Gamesa, Ruffles, Emperador, Saladitas, Sabritas, Lay’s, Rosquinhas Mabel, and Tostitos brands; cereals and snacks under the Quaker brand; and beverage concentrates, fountain syrups, and finished goods under the Pepsi, 7UP, Gatorade, Mirinda, Diet 7UP, Manzanita Sol, and Diet Pepsi brands. Its Europe Sub-Saharan Africa segment offers snack foods under the Lay’s, Walkers, Doritos, Cheetos, and Ruffles brands; cereals and snacks under the Quaker brand; beverage concentrates, fountain syrups, and finished goods under the Pepsi, 7UP, Pepsi Max, Mirinda, Diet Pepsi, and Tropicana brands; ready-to-drink tea products; and dairy products under the Chudo, Agusha, and Domik v Derevne brands. The company’s Asia, Middle East and North Africa segment provides snack foods under the Lay’s, Kurkure, Chipsy, Doritos, Cheetos, and Crunchy brands; cereals and snacks under the Quaker brand; beverage concentrates, fountain syrups, and finished goods under the Pepsi, Mirinda, 7UP, Mountain Dew, Aquafina, and Tropicana brands; and tea products. The company was founded in 1898 and is headquartered in Purchase, New York.

Tyson Foods, Inc. (TSN) dropped $-1.31 to close the day at a new closing price of $58.34, a -2.2% decrease in value from its previous closing price that moved the stock 21.03% above its 52 week low of $48.52. A total of 5.53M shares exchanged hands during the day compared with its three month average trading volume of 3.73M. The stock, which fluctuated between $58.13 and $59.74 during the day, currently situated -24.28% below its 52 week high. The stock is down by -15.34% in the past one month and down by -23.12% over the past three months. With a one year target estimate of $70.9 and RSI of 29.89, the stock still has upside potential, making it a buy for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

The Southern Company (SO) had a light trading with around 5.53M shares changing hands compared to its three month average trading volume of 5.69M. The stock traded between $47.8 and $48.38 before closing at the price of $48.31 with 1.11% change on the day. The Atlanta Georgia 30308 based company is currently trading 15.53% above its 52 week low of $43.72 and -9.59% below its 52 week high of $54.64. Both the RSI indicator and target price of 46.16 and $51.31 respectively, lead us to believe that it should be put on hold over the coming weeks.

The Southern Company, together with its subsidiaries, engages in the generation, transmission, and distribution of electricity through coal, nuclear, oil and gas, and hydro resources in the states of Alabama, Georgia, Florida, and Mississippi. The company also constructs, acquires, owns, and manages generation assets, including renewable energy projects. As of December 31, 2015, it operated 33 hydroelectric generating stations, 31 fossil fuel generating stations, 3 nuclear generating stations, 13 combined cycle/cogeneration stations, 16 solar facilities, 1 wind facility, 1 biomass facility, and 1 landfill gas facility. The company also provides digital wireless communications services with various communication options, including push to talk, cellular service, text messaging, wireless Internet access, and wireless data; and wholesale fiber optic solutions to telecommunication providers in the Southeast. The Southern Company was founded in 1945 and is headquartered in Atlanta, Georgia.

 

Stocks Trend Analysis: Tyson Foods, Inc. (TSN), Rennova Health, Inc. (RNVA), NIKE, Inc. (NKE)

Tyson Foods, Inc. (TSN) managed to rebound with the stock climbing 1.69% or $0.99 to close the day at $59.65 on light trading volume of 2.78M shares, compared to its three month average trading volume of 3.69M. The Springdale Arkansas 72762 based company has been outperforming the meat products group over the past 52 weeks, with the stock gaining 20.81%, compared to the industry which has advanced 8.25% over the same period. With RSI of 31.56, the stock should still continue to rise and get closer to its one year target estimate of $70.9, making it a hold for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

Rennova Health, Inc. (RNVA) grew with the stock adding 8.7% or $0.01 to close at $0.1 on light trading volume of 2.75M compared its three months average trading volume of 881.94K. The West Palm Beach Florida 33401 based company has been trending down for the last 52 weeks, with the shares price now -97.44% down for the period and down by -92.59% so far this year. With price target of $18.5 and a 24.69% rebound from 52-week low, Rennova Health, Inc. has plenty of upside potential, making it a hold with a view buy.

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers in the United States. It offers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices. The company provides toxicology, clinical pharmacogenetics, and esoteric testing services; develops Web-based system to place lab orders, track samples, and view test reports in real time; Web-enabled laboratory information management solutions; Medical Mime, which offers an electronic health record for substance abuse and behavioral health providers; and CollabRx that enhances cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

NIKE, Inc. (NKE) managed to rebound with the stock climbing 0.35% or $0.18 to close the day at $51.52 on lower than average trading volume of 2.74M shares, compared to its three month average trading volume of 9.41M. The Beaverton Oregon 97005 based company has been underperforming the textile – apparel footwear & accessories companies by -12.3492% for last three months and its recent losses have pulled the stock down -16.88% YTD, versus the textile – apparel footwear & accessories industry which is down -9.91% for the same period. The RSI of 52.19 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide. It offers products in nine categories, including running, NIKE basketball, the Jordan brand, football, men’s training, women’s training, action sports, sportswear, and golf. The company also markets products designed for kids, as well as for other athletic and recreational uses, such as cricket, lacrosse, tennis, volleyball, wrestling, walking, and outdoor activities. In addition, it sells sports apparel; and markets apparel with licensed college and professional team and league logos. Further, the company sells a line of performance equipment, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, golf clubs, and other equipment under the NIKE brand name for sports activities; various plastic products to other manufacturers; athletic and casual footwear, apparel, and accessories under the Jumpman trademark; action sports and youth lifestyle apparel and accessories under the Hurley trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. Additionally, it licenses agreements that permit unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores, sporting goods stores, athletic specialty stores, department stores, skate, tennis and golf shops, and other retail accounts through NIKE-owned retail stores and Internet Websites (direct to consumer operations), as well as independent distributors and licensees. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

 

Stocks Trending Alert: Gilead Sciences Inc. (GILD), Tyson Foods, Inc. (TSN), Rite Aid Corporation (RAD)

Gilead Sciences Inc. (GILD) saw its value increase by 1.13% as the stock gained $0.84 to finish the day at a closing price of $75.3. The stock was lighter in trading and has fluctuated between $71.39-$108.63 per share for the past year. The shares are down by -5.4% in the past three months and down by -10.68% over the past six months. It is currently trading 0.47% above its 20 day moving average and -1.04% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $96.19 a share over the next twelve months. The current relative strength index (RSI) reading is 48.67.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company’s products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.

Tyson Foods, Inc. (TSN) shares were down in last trading by -0.51% to $58.66. It experienced higher than average volume on day. The stock decreased in value by almost -15.01% over the past week and fell -15.03% in the past month. It is currently trading -17.23% below its 50 day moving average and -14.18% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -23.87% decrease in value from its one year high of $77.05. The RSI indicator value of 28.36, lead us to believe that it may correct downwards in the near term.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

Rite Aid Corporation (RAD) traded within a range of $7.65 to $7.82 after opening the day at $7.66. The company has seen its stock decrease in value by -0.51% so far this year. The stock was up close to 1.96% on light volume in last trading session and closed at $7.8 per share. After the recent gain, the stock is currently holding -6.02% below its 52 week high of $8.3 and 23.22% above its 12-month low of $6.33. The shares are up by over 4.42% in the last three months, and the RSI indicator value of 62.36 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, including health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs. Rite Aid Corporation has a strategic alliance with GNC. As of February 27, 2016, the company operated approximately 4,561 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

 

Stocks Trending Alert: Gilead Sciences Inc. (GILD), Tyson Foods, Inc. (TSN), Rite Aid Corporation (RAD)

Gilead Sciences Inc. (GILD) saw its value increase by 1.13% as the stock gained $0.84 to finish the day at a closing price of $75.3. The stock was lighter in trading and has fluctuated between $71.39-$108.63 per share for the past year. The shares, which traded within a range of $73.76 to $75.35 during the day, are down by -5.4% in the past three months and down by -10.68% over the past six months. It is currently trading 0.47% above its 20 day moving average and -1.04% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $96.19 a share over the next twelve months. The current relative strength index (RSI) reading is 48.67.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company’s products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.

Tyson Foods, Inc. (TSN) shares were down in last trading by -0.51% to $58.66. It experienced higher than average volume on day. The stock decreased in value by almost -15.01% over the past week and fell -15.03% in the past month. It is currently trading -17.23% below its 50 day moving average and -14.18% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -23.87% decrease in value from its one year high of $77.05. The RSI indicator value of 28.36, lead us to believe that it may correct downwards in the near term.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

Rite Aid Corporation (RAD) traded within a range of $7.65 to $7.82 after opening the day at $7.66. The company has seen its stock decrease in value by -0.51% so far this year. The stock was up close to 1.96% on light volume in last trading session and closed at $7.8 per share. After the recent gain, the stock is currently holding -6.02% below its 52 week high of $8.3 and 23.22% above its 12-month low of $6.33. The shares are up by over 4.42% in the last three months, and the RSI indicator value of 62.36 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, including health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs. Rite Aid Corporation has a strategic alliance with GNC. As of February 27, 2016, the company operated approximately 4,561 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

 

Momentum Stocks in Focus: Tyson Foods, Inc. (TSN), CVS Health Corporation (CVS), Morgan Stanley (MS)

Tyson Foods, Inc. (TSN) managed to rebound with the stock climbing 2.36% or $1.36 to close the day at $58.96 on light trading volume of 12.52M shares, compared to its three month average trading volume of 3.45M. The Springdale Arkansas 72762 based company has been outperforming the meat products group over the past 52 weeks, with the stock gaining 23.78%, compared to the industry which has advanced 12.67% over the same period. With RSI of 28.67, the stock should still continue to rise and get closer to its one year target estimate of $77, making it a hold for now.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Chicken, Beef, Pork, and Prepared Foods. The company raises and processes chickens into fresh, frozen, and value-added chicken products; processes live fed cattle and live market hogs; and fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully-cooked meats. It also supplies poultry breeding stock; sells allied products, such as hide and meats; and manufactures and markets frozen and refrigerated food products, including pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, pizza crusts and toppings, flour and corn tortilla products, desserts, appetizers, snacks, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, breadsticks, and processed meats. Tyson Foods, Inc. offers its products primarily under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Van’s, Sara Lee, Chef Pierre, Ball Park, Wright, Aidells, State Fair, Gallo Salame, and Golden Island brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies. Tyson Foods, Inc. was founded in 1935 and is headquartered in Springdale, Arkansas.

CVS Health Corporation (CVS) retreated with the stock falling -0.82% or $-0.61 to close at $73.59 on light trading volume of 12.42M compared its three months average trading volume of 7.38M. The Woonsocket Rhode Island 02895 based company operating under the Health Care Plans industry has been trending down for the last 52 weeks, with the shares price now -18.17% down for the period and down by -23.37% so far this year. With price target of $88.02 and a 6.19% rebound from 52-week low, CVS Health Corporation has plenty of upside potential, making it a hold with a view buy.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Morgan Stanley (MS) failed to extend gains with the stock declining -0.05% or $-0.02 to close the day at $40.54 on higher than average trading volume of 12.33M shares, compared to its three month average trading volume of 12.25M. The New York New York 10036 based company has been outperforming the investment brokerage – national companies by 31.7111% for last three months and its recent gains have pushed the stock slightly up 30.57% YTD, versus the investment brokerage – national industry which is up 17.37% for the same period. The RSI of 81.97 indicates the stock is overbought at the current levels, sell for now.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The company’s Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides sales and trading services, such as sales, financing, and market-making services in equity securities and fixed income products, including foreign exchange and commodities, as well as prime brokerage services; and corporate lending services, credit products, and investments and research services. Its Wealth Management segment offers various financial services and solutions covering brokerage and investment advisory services, market-making services in fixed income securities, financial and wealth planning services, annuity and insurance products, credit and other lending products, and banking and retirement plan services to individual investors, small-to-medium sized businesses, and institutions. The company’s Investment Management segment provides various investment strategies and products comprising asset management, including equity, fixed income, liquidity, alternatives, and managed futures products. This segment is also involved in merchant banking and real estate investing businesses. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.